Adenosine(5') oligophospho-(5') guanosines and guanosine(5') oligophospho-(5') guanosines in human platelets

Journal of Clinical Investigation

Volumn 101, Issue 3, 1998, Pages 682-688

  Schlüter, Hartmut ^a   Groß, Isolde ^a   Bachmann, Jürgen ^a   Kaufmann, Raimund ^b   Van Der Giet, Marcus ^a   Tepel, Martin ^a   Nofer, Jerzy Roch ^c   Assmann, Gerd ^c   Karas, Michael ^c   Jankowski, Joachim ^a   Zidek, Walter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cytosolic free Ca2+ concentration; Dinucleoside polyphosphates; Growth factors; Platelets; Vascular smooth muscle cells

Indexed keywords

ADENOSINE DERIVATIVE; GUANOSINE DERIVATIVE; GUANOSINE PHOSPHATE; NUCLEOSIDE DERIVATIVE;

ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0037985197     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119882     Document Type: Article

References (31)

1. Fredholm, B.B., M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff, and M. Williams. 1994. Nomenclature and classification of purinoceptors. Pharmamacol. Rev. 46:143-156.
2. 2-purinergic receptors. Am. J. Physiol. 263:F374-F383.
3. Malam-Souley, R., M. Campan, A.-P. Gadeau, and C. Desgranges. 1993. Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am. J. Physiol. 264:C783-C788.
4. Erlinge, D., H. Yoo, L. Edvinsson, D.J. Reis, and C. Wahlestedt. 1993. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am. J. Physiol. 265:H1089-H1097.
5. Dalziel, H.H., and D.P. Westfall. 1994. Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol. Rev. 46:449-466.
6. Aalkjaer, C. 1990. Regulation of intracellular pH and its role in vascular smooth muscle function. J Hypertens. 8:197-206.
7. Schlüter, H., E. Offers, G. Brüggemann, M. van der Giet, M. Tepel, E. Nordhoff, M. Karas, C. Spieker, H. Witzel, and W. Zidek. 1994. Diadenosine phosphates and the physiological control of blood pressure. Nature. 367:186-188.
8. Pintor, J., and M.T. Miras-Portugal. 1995. A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes. Br. J. Pharmacol. 115:895-902.
9. Barnes, L.D., A.K. Robinson, C.H. Mumford, and P.N. Garrison. 1985. Assay of diadenosine tetraphosphate hydrolytic enzymes by boronate chromatography. Anal. Biochem. 144:296-304.
10. Nordhoff, E., A. Ingendoh, R. Cramer, A. Overberg, B. Stahl, M. Karas, and F. Hillenkamp. 1992. Matrix-assisted Iaser desorption/ionization mass spectrometry of nucleic acids with wavelengths in the ultraviolet and infrared. Rapid Commun. Mass Spectrom. 6:771-776.
11. Kaufmann, R., D. Kirsch, and B. Spengler. 1994. Sequencing of peptides in a time-of-flight mass spectrometer: evaluation of postsource decay following matrix-assisted laser desorption ionisation (MALDI). Int. J. Mass Spectrm. Ion Proc. 131:355-385.
12. Ng, K.E., and L.E. Orgel. 1987. The action of water-soluble carbodiimide on adenosine-5′-polyphosphates. Nucleic Acids Res. 15:3573-3580.
13. Sulkowski, E., and S. Laskowski. 1971. Inactivation of 5′-nucleotidase in commercial preparations of venom exonuclease (phosphodiesterase). Biochim. Biophys. Acta. 240:443-447.
14. Heidenreich, S., M. Tepel, H. Schlüter, B. Harrach, and W. Zidek. 1995. Regulation of rat mesangial cell growth by diadenosine phosphates. J. Clin. Invest. 95:2862-2867.
15. Agha, A., H. Schlüter, S. König, K. Biel, M. Tepel, and W. Zidek. 1992. A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives. J. Vasc. Res. 29:281-289.
16. Lever, A.F. 1990. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels. J. Hypertens. 8:1065-1066.
17. Palfi, Z., G. Suranyi, and G. Borbely. 1991. Alterations in the accumulation of adenylylated nucleotides in heavy-metal-ion-stressed and heat-stressed Synechococcus sp. strain PCC 6301. a cyanobacterium, in light and dark. Biochem. J. 276:487-491.
18. 4A phosphorylase I in Saccharomyces cerevisiae. J. Bacteriol. 173:7875-7880.
19. Prescott, M., A.D. Milne, and A.G. McLennan. 1989. Characterization of the bis(5′-nucleosidyl) tetraphosphate pyrophosphohydrolase from encysted embryos of the brine shrimp Artemia. Biochem. J. 259:831-838.
20. Redon, J., and D.C. Batlle. 1994. Regulation of intracellular pH in the spontaneously hypertensive rat: role of bicarbonate-dependent transporters. Hypertension. 23:503-512.
21. - exchange by stimulation of acid secretion in the parietal cell. J. Biol. Chem. 263:14703-14711.
22. Zamecnik, P.C., M.L. Stephenson, C.M. Janeway, and K. Randerath. 1966. Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase. Biochem. Biophys. Res. Commun. 24:91-97.
23. + antiporter characteristics. Clin. Sci. 77:417-423.
24. + exchange in patients with end-stage renal failure. Life Sci. 59:1545-1552.
25. 4A and Other Dinucleosides Polyphosphates. A.G. McLennan, editor. CRC Press, Inc., Boca Raton, FL. 81-133.
26. 3A) mediates human platelet aggregation by liberation of ADP. Biochem. Biophys. Res. Commun. 118:704-709.
27. 3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes. Eur. J. Biochem. 173:241-251.
28. 3A) in human platelets. Biochem. Biophys. Res. Commun. 115:253-260.
29. 4A and Other Dinucleoside Polyphosphates. CRC Press Inc., Ann Arbor, MI.
30. Ralevic, V., C.H.V. Hoyle, and G. Burnstock. 1995. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. J. Physiol. 483(Pt.3):703-713.
31. Erlinge, D., J. You, C. Wahlestedt, and L. Edvinsson. 1995. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur. J. Pharmacol. Mol. Pharmacol. 289:135-149.